NXGL

+ Watchlist + Portfolio

NexGel, Inc

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.18
52-Week Range: $0.16 – $2.89
Market Cap: $1.70M
P/E (TTM): —
EPS (TTM): -0.74
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.34
PEG Ratio: —
Return on Equity: -115.06%
Return on Assets: -18.68%
Gross Margin: 35.08%
Operating Margin: -67.96%
Profit Margin: -51.26%
Current Ratio: 0.43
Debt/Equity: 1.36
Total Debt: $7.46M
Free Cash Flow: $8.45M
Revenue Growth: 27.80%
Earnings Growth: —
Enterprise Value: $9.18M

NXGL Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$2.05M	$4.09M	$8.69M	$11.42M
Cost of Revenue	$1.79M	$3.71M	$5.94M	$6.91M
Gross Profit	$256.00K	$374.00K	$2.75M	$4.51M
Research & Development	$367.00K	$103.00K	$78.00K	$2.00K
Selling, General & Admin	$2.82M	$3.40M	$6.22M	$7.86M
Operating Expenses	$3.60M	$3.85M	$6.30M	$7.86M
Operating Income	-$3.35M	-$3.48M	-$3.55M	-$3.35M
EBITDA	-$3.11M	-$2.73M	-$2.72M	-$2.12M
Pretax Income	-$4.75M	-$3.19M	-$3.46M	-$2.89M
Income Tax	$0.00	$0.00	$0.00	$0.00
Net Income	-$4.75M	-$3.16M	-$3.28M	-$3.00M
Diluted EPS	-0.85	-0.56	-0.50	-0.38
Diluted Shares	5.57M	5.67M	6.51M	7.85M

NXGL Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.10M	$2.70M	$1.81M	$317.00K
Receivables	$222.00K	$633.00K	$933.00K	$673.00K
Inventory	$502.00K	$1.32M	$1.75M	$2.11M
Current Assets	$7.50M	$5.05M	$5.11M	$4.34M
Total Assets	$10.36M	$9.96M	$10.98M	$10.46M
Current Liabilities	$859.00K	$2.55M	$2.47M	$2.96M
Long-Term Debt	$268.00K	$513.00K	$588.00K	$489.00K
Total Debt	$2.08M	$2.80M	$2.83M	$3.09M
Total Liabilities	$2.72M	$4.79M	$4.90M	$5.57M
Retained Earnings	-$11.56M	-$14.71M	-$18.00M	-$21.00M
Shareholders' Equity	$7.64M	$4.70M	$5.75M	$4.46M
Working Capital	$6.65M	$2.50M	$2.64M	$1.38M
Net Debt	—	—	—	$271.00K

NXGL Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$2.99M	-$3.24M	-$3.87M	-$1.31M
Capital Expenditure	-$96.00K	-$696.00K	-$443.00K	-$68.00K
Free Cash Flow	-$3.09M	-$3.93M	-$4.31M	-$1.38M
Depreciation & Amortisation	$301.00K	$443.00K	$665.00K	$740.00K
Stock-Based Compensation	$298.00K	$217.00K	$367.00K	$654.00K
Investing Cash Flow	-$5.59M	$4.46M	-$775.00K	-$68.00K
Financing Cash Flow	-$3.66M	$379.00K	$3.75M	$630.00K
Net Change in Cash	-$12.25M	$1.60M	-$893.00K	-$749.00K

NXGL Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$2.81M	$2.88M	$2.93M	$2.80M	$2.65M	$3.69M
Cost of Revenue	$1.62M	$1.63M	$1.69M	$1.98M	$1.59M	$2.58M
Gross Profit	$1.19M	$1.26M	$1.24M	$819.00K	$1.06M	$1.11M
Research & Development	$1.00K	$0.00	$7.00K	-$6.00K	$0.00	$20.00K
Selling, General & Admin	$1.96M	$1.89M	$1.88M	$2.27M	$2.02M	$3.59M
Operating Expenses	$1.97M	$1.89M	$1.97M	$2.03M	$2.02M	$3.61M
Operating Income	-$777.00K	-$636.00K	-$725.00K	-$1.21M	-$958.00K	-$2.50M
EBITDA	-$485.00K	-$467.00K	-$683.00K	-$523.00K	-$657.00K	-$1.52M
Pretax Income	-$678.00K	-$640.00K	-$647.00K	-$928.00K	-$871.00K	-$3.61M
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income	-$712.00K	-$665.00K	-$653.00K	-$970.00K	-$927.00K	-$3.63M
Diluted EPS	-0.09	-0.09	-0.08	—	-0.11	-0.40
Diluted Shares	7.65M	7.65M	7.97M	—	8.20M	9.01M

NXGL Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$1.19M	$725.00K	$938.00K	$317.00K	$208.00K	$492.00K
Receivables	$926.00K	$753.00K	$839.00K	$673.00K	$662.00K	$1.08M
Inventory	$1.85M	$1.82M	$2.02M	$2.11M	$2.26M	$2.30M
Current Assets	$4.74M	$4.16M	$5.60M	$4.34M	$5.64M	$6.17M
Total Assets	$10.44M	$9.71M	$11.62M	$10.46M	$11.60M	$26.45M
Current Liabilities	$2.52M	$2.40M	$3.31M	$2.96M	$3.31M	$14.44M
Long-Term Debt	$563.00K	$539.00K	$515.00K	$489.00K	$1.77M	$3.49M
Total Debt	$2.74M	$2.65M	$3.19M	$3.09M	$4.29M	$7.46M
Total Liabilities	$4.87M	$4.66M	$6.04M	$5.57M	$7.12M	$20.98M
Retained Earnings	-$18.71M	-$19.37M	-$20.03M	-$21.00M	-$21.92M	-$25.56M
Shareholders' Equity	$5.21M	$4.67M	$5.19M	$4.46M	$3.99M	$4.95M
Working Capital	$2.22M	$1.77M	$2.29M	$1.38M	$2.32M	-$8.27M
Net Debt	—	—	—	$271.00K	$1.67M	$3.10M

NXGL Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$400.00K	-$407.00K	-$785.00K	$281.00K	-$504.00K	-$2.20M
Capital Expenditure	—	—	-$8.00K	-$40.00K	-$9.00K	-$6.58M
Free Cash Flow	-$400.00K	-$427.00K	-$793.00K	$241.00K	-$513.00K	-$8.78M
Depreciation & Amortisation	$172.00K	$169.00K	-$4.00K	$403.00K	$172.00K	$981.00K
Stock-Based Compensation	$166.00K	$127.00K	$205.00K	$156.00K	$143.00K	$119.00K
Investing Cash Flow	$0.00	-$20.00K	-$8.00K	-$40.00K	-$9.00K	-$6.58M
Financing Cash Flow	-$215.00K	-$40.00K	$1.93M	-$1.04M	$1.58M	$8.36M
Net Change in Cash	-$615.00K	-$467.00K	$1.13M	-$800.00K	$1.06M	-$416.00K

Market Snapshot

About

NexGel, Inc. develops and manufactures hydrogel technology products for medical and consumer applications. The company focuses on ultra-gentle, high-water-content hydrogels used in wound care, medical electrodes, and other healthcare products. NexGel serves medical device manufacturers and other customers seeking advanced hydrogel solutions.